Testing effectiveness (Phase 2)Study completedNCT01824615
What this trial is testing
Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma
Who this might be right for
Ovarian CancerAdverse Effects
Cathay General Hospital 30
Showing 20 of 0 results